Home
About
Overview
Sharing Data
ORCID
Help
History (79)
Geographic atrophy in age-related macular degeneration and TLR3.
Emergency Department Length of Stay and Outcome after Ischemic Stroke.
Effects of macrophage colony-stimulating factor (M-CSF) on the development, differentiation, and maturation of marginal metallophilic macrophages and marginal zone macrophages in the spleen of osteopetrosis (op) mutant mice lacking functional M-CSF activity.
Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans.
Incretin-based therapeutics for the treatment of neurodegenerative diseases.
See All 79 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Incretin-based therapeutics for the treatment of neurodegenerative diseases.
Vear A, Heneka MT, Clemmensen C. Incretin-based therapeutics for the treatment of neurodegenerative diseases. Nat Metab. 2025 Apr; 7(4):679-696.
View in:
PubMed
subject areas
Animals
Glucagon-Like Peptide-1 Receptor
Humans
Incretins
Neurodegenerative Diseases
authors with profiles
Michael Thomas Heneka MD